Invion Limited (ASX:IVX)
Australia · Delayed Price · Currency is AUD 0.0400
0.00 (0.00%)
Sep 7, 2026, 3:35 PM AEST
Invion Revenue
In the fiscal year ending June 30, 2026, Invion had annual revenue of 384.71K AUD. Invion had revenue of 384.71K in the half year ending June 30, 2026, a decrease of -73.75%.
Revenue
384.71K
Revenue Growth
n/a
P/S Ratio
11.35
Revenue / Employee
96.18K
Employees
4
Market Cap
4.37M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 384.71K | - | - |
| Jun 30, 2025 | - | - | - |
| Jun 30, 2024 | 3.69M | -410.46K | -10.00% |
| Jun 30, 2023 | 4.10M | 812.95K | 24.70% |
| Jun 30, 2022 | 3.29M | 961.74K | 41.28% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vitura Health | 131.16M |
| ECS Botanics Holdings | 21.02M |
| IDT Australia | 20.38M |
| Elixinol Wellness | 15.90M |
| Epsilon Healthcare | 13.58M |
| Peak Processing | 12.51M |
| Cann Group | 9.65M |
| Syntara | 6.93M |